Sourcebio International (LON:SBI) Shares Up 4.5% – Should You Buy?

Sourcebio International Plc (LON:SBI)’s share price shot up 4.5% on Tuesday . The company traded as high as GBX 125 ($1.63) and last traded at GBX 115 ($1.50). 1,571,282 shares traded hands during mid-day trading, an increase of 931% from the average session volume of 152,444 shares. The stock had previously closed at GBX 110 ($1.43).

Sourcebio International Price Performance

The stock’s 50 day moving average price is GBX 115 and its two-hundred day moving average price is GBX 115. The company has a debt-to-equity ratio of 35.10, a current ratio of 1.91 and a quick ratio of 1.78. The firm has a market capitalization of £85.31 million and a price-to-earnings ratio of 1,277.78.

Sourcebio International Company Profile

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services.